Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
$10.7B | $6.46 | 8.65% | -20.3% | $662.68 |
|
BKYI
BIO-key International, Inc.
|
$1.8M | -$0.12 | -16.08% | -69.31% | $2.00 |
|
CIX
CompX International, Inc.
|
-- | -- | -- | -- | -- |
|
IVDA
Iveda Solutions, Inc.
|
$2.5M | -$0.40 | 186.45% | -60.98% | -- |
|
NSSC
Napco Security Technologies, Inc.
|
$46.9M | $0.30 | 11.37% | 8.93% | $48.83 |
|
VRME
VerifyMe, Inc.
|
$4.7M | -$0.03 | -55.01% | -86.88% | $1.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
$580.06 | $662.68 | $82.8B | 20.82x | $2.31 | 1.55% | 2.05x |
|
BKYI
BIO-key International, Inc.
|
$0.62 | $2.00 | $6.7M | -- | $0.00 | 0% | 0.49x |
|
CIX
CompX International, Inc.
|
$22.93 | -- | $282.6M | 14.62x | $0.30 | 5.23% | 1.78x |
|
IVDA
Iveda Solutions, Inc.
|
$0.86 | -- | $5.1M | -- | $0.00 | 0% | 0.39x |
|
NSSC
Napco Security Technologies, Inc.
|
$42.19 | $48.83 | $1.5B | 34.35x | $0.14 | 1.29% | 8.17x |
|
VRME
VerifyMe, Inc.
|
$0.67 | $1.25 | $8.4M | -- | $0.00 | 0% | 0.37x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
52.25% | 0.000 | 20.1% | 0.86x |
|
BKYI
BIO-key International, Inc.
|
19.49% | -1.219 | 27.8% | 1.14x |
|
CIX
CompX International, Inc.
|
-- | 0.047 | -- | 4.23x |
|
IVDA
Iveda Solutions, Inc.
|
16.95% | -5.201 | 12.88% | 2.95x |
|
NSSC
Napco Security Technologies, Inc.
|
2.92% | 2.992 | 0.67% | 5.56x |
|
VRME
VerifyMe, Inc.
|
6.98% | 1.034 | 7.66% | 3.54x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
$2.2B | $1.2B | 12.21% | 26.28% | 11.92% | $1.3B |
|
BKYI
BIO-key International, Inc.
|
$1.2M | -$892.2K | -70.08% | -91.16% | -57.57% | -$1.1M |
|
CIX
CompX International, Inc.
|
$11M | $4.8M | 13.3% | 13.3% | 11.92% | $5.3M |
|
IVDA
Iveda Solutions, Inc.
|
$517.3K | -$214.3K | -84.84% | -112.18% | -12.97% | -$315.8K |
|
NSSC
Napco Security Technologies, Inc.
|
$27.8M | $13.6M | 25.05% | 25.83% | 27.75% | $11.4M |
|
VRME
VerifyMe, Inc.
|
$1.8M | $418K | -34.76% | -38.89% | 8.31% | $9K |
BIO-key International, Inc. has a net margin of 10.55% compared to Northrop Grumman Corp.'s net margin of -62.26%. Northrop Grumman Corp.'s return on equity of 26.28% beat BIO-key International, Inc.'s return on equity of -91.16%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
21.37% | $7.67 | $33.5B |
|
BKYI
BIO-key International, Inc.
|
76.9% | -$0.15 | $7.5M |
Northrop Grumman Corp. has a consensus price target of $662.68, signalling upside risk potential of 14.24%. On the other hand BIO-key International, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 220%. Given that BIO-key International, Inc. has higher upside potential than Northrop Grumman Corp., analysts believe BIO-key International, Inc. is more attractive than Northrop Grumman Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
9 | 10 | 0 |
|
BKYI
BIO-key International, Inc.
|
0 | 0 | 0 |
Northrop Grumman Corp. has a beta of 0.046, which suggesting that the stock is 95.427% less volatile than S&P 500. In comparison BIO-key International, Inc. has a beta of 0.355, suggesting its less volatile than the S&P 500 by 64.505%.
Northrop Grumman Corp. has a quarterly dividend of $2.31 per share corresponding to a yield of 1.55%. BIO-key International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Northrop Grumman Corp. pays 28.41% of its earnings as a dividend. BIO-key International, Inc. pays out -- of its earnings as a dividend. Northrop Grumman Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Northrop Grumman Corp. quarterly revenues are $10.4B, which are larger than BIO-key International, Inc. quarterly revenues of $1.5M. Northrop Grumman Corp.'s net income of $1.1B is higher than BIO-key International, Inc.'s net income of -$964.8K. Notably, Northrop Grumman Corp.'s price-to-earnings ratio is 20.82x while BIO-key International, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Northrop Grumman Corp. is 2.05x versus 0.49x for BIO-key International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
2.05x | 20.82x | $10.4B | $1.1B |
|
BKYI
BIO-key International, Inc.
|
0.49x | -- | $1.5M | -$964.8K |
CompX International, Inc. has a net margin of 10.55% compared to Northrop Grumman Corp.'s net margin of 10.57%. Northrop Grumman Corp.'s return on equity of 26.28% beat CompX International, Inc.'s return on equity of 13.3%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
21.37% | $7.67 | $33.5B |
|
CIX
CompX International, Inc.
|
27.61% | $0.34 | $137.7M |
Northrop Grumman Corp. has a consensus price target of $662.68, signalling upside risk potential of 14.24%. On the other hand CompX International, Inc. has an analysts' consensus of -- which suggests that it could grow by 15.12%. Given that CompX International, Inc. has higher upside potential than Northrop Grumman Corp., analysts believe CompX International, Inc. is more attractive than Northrop Grumman Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
9 | 10 | 0 |
|
CIX
CompX International, Inc.
|
0 | 0 | 0 |
Northrop Grumman Corp. has a beta of 0.046, which suggesting that the stock is 95.427% less volatile than S&P 500. In comparison CompX International, Inc. has a beta of 1.060, suggesting its more volatile than the S&P 500 by 6.022%.
Northrop Grumman Corp. has a quarterly dividend of $2.31 per share corresponding to a yield of 1.55%. CompX International, Inc. offers a yield of 5.23% to investors and pays a quarterly dividend of $0.30 per share. Northrop Grumman Corp. pays 28.41% of its earnings as a dividend. CompX International, Inc. pays out 89.11% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
Northrop Grumman Corp. quarterly revenues are $10.4B, which are larger than CompX International, Inc. quarterly revenues of $40M. Northrop Grumman Corp.'s net income of $1.1B is higher than CompX International, Inc.'s net income of $4.2M. Notably, Northrop Grumman Corp.'s price-to-earnings ratio is 20.82x while CompX International, Inc.'s PE ratio is 14.62x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Northrop Grumman Corp. is 2.05x versus 1.78x for CompX International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
2.05x | 20.82x | $10.4B | $1.1B |
|
CIX
CompX International, Inc.
|
1.78x | 14.62x | $40M | $4.2M |
Iveda Solutions, Inc. has a net margin of 10.55% compared to Northrop Grumman Corp.'s net margin of -13.4%. Northrop Grumman Corp.'s return on equity of 26.28% beat Iveda Solutions, Inc.'s return on equity of -112.18%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
21.37% | $7.67 | $33.5B |
|
IVDA
Iveda Solutions, Inc.
|
31.32% | -$0.07 | $4.5M |
Northrop Grumman Corp. has a consensus price target of $662.68, signalling upside risk potential of 14.24%. On the other hand Iveda Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 829.69%. Given that Iveda Solutions, Inc. has higher upside potential than Northrop Grumman Corp., analysts believe Iveda Solutions, Inc. is more attractive than Northrop Grumman Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
9 | 10 | 0 |
|
IVDA
Iveda Solutions, Inc.
|
0 | 0 | 0 |
Northrop Grumman Corp. has a beta of 0.046, which suggesting that the stock is 95.427% less volatile than S&P 500. In comparison Iveda Solutions, Inc. has a beta of 0.845, suggesting its less volatile than the S&P 500 by 15.456%.
Northrop Grumman Corp. has a quarterly dividend of $2.31 per share corresponding to a yield of 1.55%. Iveda Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Northrop Grumman Corp. pays 28.41% of its earnings as a dividend. Iveda Solutions, Inc. pays out -- of its earnings as a dividend. Northrop Grumman Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Northrop Grumman Corp. quarterly revenues are $10.4B, which are larger than Iveda Solutions, Inc. quarterly revenues of $1.7M. Northrop Grumman Corp.'s net income of $1.1B is higher than Iveda Solutions, Inc.'s net income of -$221.3K. Notably, Northrop Grumman Corp.'s price-to-earnings ratio is 20.82x while Iveda Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Northrop Grumman Corp. is 2.05x versus 0.39x for Iveda Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
2.05x | 20.82x | $10.4B | $1.1B |
|
IVDA
Iveda Solutions, Inc.
|
0.39x | -- | $1.7M | -$221.3K |
Napco Security Technologies, Inc. has a net margin of 10.55% compared to Northrop Grumman Corp.'s net margin of 24.74%. Northrop Grumman Corp.'s return on equity of 26.28% beat Napco Security Technologies, Inc.'s return on equity of 25.83%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
21.37% | $7.67 | $33.5B |
|
NSSC
Napco Security Technologies, Inc.
|
56.63% | $0.34 | $181.4M |
Northrop Grumman Corp. has a consensus price target of $662.68, signalling upside risk potential of 14.24%. On the other hand Napco Security Technologies, Inc. has an analysts' consensus of $48.83 which suggests that it could grow by 15.75%. Given that Napco Security Technologies, Inc. has higher upside potential than Northrop Grumman Corp., analysts believe Napco Security Technologies, Inc. is more attractive than Northrop Grumman Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
9 | 10 | 0 |
|
NSSC
Napco Security Technologies, Inc.
|
5 | 0 | 0 |
Northrop Grumman Corp. has a beta of 0.046, which suggesting that the stock is 95.427% less volatile than S&P 500. In comparison Napco Security Technologies, Inc. has a beta of 1.473, suggesting its more volatile than the S&P 500 by 47.323%.
Northrop Grumman Corp. has a quarterly dividend of $2.31 per share corresponding to a yield of 1.55%. Napco Security Technologies, Inc. offers a yield of 1.29% to investors and pays a quarterly dividend of $0.14 per share. Northrop Grumman Corp. pays 28.41% of its earnings as a dividend. Napco Security Technologies, Inc. pays out 43.31% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
Northrop Grumman Corp. quarterly revenues are $10.4B, which are larger than Napco Security Technologies, Inc. quarterly revenues of $49.2M. Northrop Grumman Corp.'s net income of $1.1B is higher than Napco Security Technologies, Inc.'s net income of $12.2M. Notably, Northrop Grumman Corp.'s price-to-earnings ratio is 20.82x while Napco Security Technologies, Inc.'s PE ratio is 34.35x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Northrop Grumman Corp. is 2.05x versus 8.17x for Napco Security Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
2.05x | 20.82x | $10.4B | $1.1B |
|
NSSC
Napco Security Technologies, Inc.
|
8.17x | 34.35x | $49.2M | $12.2M |
VerifyMe, Inc. has a net margin of 10.55% compared to Northrop Grumman Corp.'s net margin of -66.68%. Northrop Grumman Corp.'s return on equity of 26.28% beat VerifyMe, Inc.'s return on equity of -38.89%.
| Company | Gross Margin | Earnings Per Share | Invested Capital |
|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
21.37% | $7.67 | $33.5B |
|
VRME
VerifyMe, Inc.
|
35.61% | -$0.26 | $11.9M |
Northrop Grumman Corp. has a consensus price target of $662.68, signalling upside risk potential of 14.24%. On the other hand VerifyMe, Inc. has an analysts' consensus of $1.25 which suggests that it could grow by 85.98%. Given that VerifyMe, Inc. has higher upside potential than Northrop Grumman Corp., analysts believe VerifyMe, Inc. is more attractive than Northrop Grumman Corp..
| Company | Buy Ratings | Hold Ratings | Sell Ratings |
|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
9 | 10 | 0 |
|
VRME
VerifyMe, Inc.
|
0 | 0 | 0 |
Northrop Grumman Corp. has a beta of 0.046, which suggesting that the stock is 95.427% less volatile than S&P 500. In comparison VerifyMe, Inc. has a beta of 0.294, suggesting its less volatile than the S&P 500 by 70.591%.
Northrop Grumman Corp. has a quarterly dividend of $2.31 per share corresponding to a yield of 1.55%. VerifyMe, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Northrop Grumman Corp. pays 28.41% of its earnings as a dividend. VerifyMe, Inc. pays out -- of its earnings as a dividend. Northrop Grumman Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
Northrop Grumman Corp. quarterly revenues are $10.4B, which are larger than VerifyMe, Inc. quarterly revenues of $5M. Northrop Grumman Corp.'s net income of $1.1B is higher than VerifyMe, Inc.'s net income of -$3.4M. Notably, Northrop Grumman Corp.'s price-to-earnings ratio is 20.82x while VerifyMe, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Northrop Grumman Corp. is 2.05x versus 0.37x for VerifyMe, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
| Company | Price/Sales Ratio | Price/Earnings Ratio | Quarterly Revenue | Quarterly Net Income |
|---|---|---|---|---|
|
NOC
Northrop Grumman Corp.
|
2.05x | 20.82x | $10.4B | $1.1B |
|
VRME
VerifyMe, Inc.
|
0.37x | -- | $5M | -$3.4M |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.